NCT05016908
Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Minor Enrollment closed, study ongoing Show 5 more changesShow less
- Primary completion date: Nov 2026 to Dec 2026
- Eligibility criteria expanded, about 6 words
- Site details revised at 2 of 2 sites
- Collaborators: details revised at 1 of 1 entry
- Publications: details revised at 2 of 2 entries
- Notable Primary completion date: Nov 2023 to Nov 2026
- Study completion date: May 2024 to Nov 2027
- Minor Site details revised at 2 of 2 sitesv4
- Notable Primary completion date: Nov 2022 to Nov 2023
- Study completion date: Nov 2023 to May 2024
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Extracellular RNA in biofluids
Timeframe: 4 years
Arms and interventions
Biofluid collection
Eligible volunteers will be asked to provide a single urine sample and undergo a single blood draw.
Sites
2 sites in 1 country